Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Identifying molecular signalling cascades that regulate microglial phagocytosis in Alzheimer's disease.

FY 2021-22

Summary
Microglia are a class of brain immune cells that play an important role in health and disease. In the healthy brain, microglia can remove pathogens, naturally aged brain cells, and dysfunctional synapses through the process of phagocytosis. In Alzheimers disease, there is a build-up of toxic Amyloid beta (Aβ), that stimulates microglia to release inflammatory signals leading to an inflamed state in the central nervous system, and reduces ability of microglia to control phagocytosis. In this state, microglia will start to engulf healthy neurons and synapses, while no longer removing Aβ as efficiently. These changes interfere with communication between neurons, and can lead to the memory and learning problems seen in patients with Alzheimers disease (AD).We know that a protein expressed in microglia, called PARP-1, becomes activated during inflammation, and contributes to the microglial inflammatory response. We propose that Aβ accumulation stimulates PARP-1, which produces a series of signalling events that ultimately activate a microglial ion channel called TRPM2. We propose that this promotes continuous activation of PARP-1 and leads to decreased control of microglial phagocytosis targets. In this way, microglia may incorrectly target functional neurons and synapses for degradation.In this study, we use microglial cell cultures to define the mechanism behind how PARP-1 controls phagocytosis, whether desired (Aβ, pathogen) or not desired (functional neurons/synapses). This will allow us to identify potential therapeutic targets to boost the control of microglial phagocytosis in Alzheimer's disease conditions ; for example, inhibiting the phagocytosis of viable neurons/synapses, while still allowing for phagocytosis of Aβ and pathogens.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466716
Name
Lamont Alana
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying molecular signalling cascades that regulate microglial phagocytosis in Alzheimer's disease.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Microglia; Neurodegenerative Diseases; Neuroinflammation; Neuroscience; Neurotoxicity; Phagocytosis
Abstract
Microglia are a class of brain immune cells that play an important role in health and disease. In the healthy brain, microglia can remove pathogens, naturally aged brain cells, and dysfunctional synapses through the process of phagocytosis. In Alzheimers disease, there is a build-up of toxic Amyloid beta (Aβ), that stimulates microglia to release inflammatory signals leading to an inflamed state in the central nervous system, and reduces ability of microglia to control phagocytosis. In this state, microglia will start to engulf healthy neurons and synapses, while no longer removing Aβ as efficiently. These changes interfere with communication between neurons, and can lead to the memory and learning problems seen in patients with Alzheimers disease (AD).We know that a protein expressed in microglia, called PARP-1, becomes activated during inflammation, and contributes to the microglial inflammatory response. We propose that Aβ accumulation stimulates PARP-1, which produces a series of signalling events that ultimately activate a microglial ion channel called TRPM2. We propose that this promotes continuous activation of PARP-1 and leads to decreased control of microglial phagocytosis targets. In this way, microglia may incorrectly target functional neurons and synapses for degradation.In this study, we use microglial cell cultures to define the mechanism behind how PARP-1 controls phagocytosis, whether desired (Aβ, pathogen) or not desired (functional neurons/synapses). This will allow us to identify potential therapeutic targets to boost the control of microglial phagocytosis in Alzheimer's disease conditions ; for example, inhibiting the phagocytosis of viable neurons/synapses, while still allowing for phagocytosis of Aβ and pathogens.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lamont, Alana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~